Meet The Eight Startups That Won The National Technology Awards 2023
As many as eight Indian startups have emerged as the winners of the National Technology Awards 2023 across categories and industries.
Source: inc42.com
📰 Indusage Partners News
Indusage Partners News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Indusage Partners. Real-time updates on events, politics, business and more.
ideaForge Bags SEBI's Nod For IPO As Drone Explodes
After one of its drones exploded in Chhattisgarh and injuring, ideaForge has received the final approval from SEBI for its IPO plans.
Source: inc42.com
After A Spate Of EV Fires, IPO-Bound ideaForge's Drone Explodes Now
A drone belonging to deeptech startup ideaForge exploded into flames in Chhattisgarh’s Raigarh on April 27, injuring four persons.
Rahul Singh Ankit Mehta Vipul Joshi Ministry Of Civil Aviation Exchange Board Of India Garuda Aerospace
Source: inc42.com
ideaForge DRHP: Decoding Infosys-Backed Drone Startup's Shareholding Pattern
IPO-bound ideaForge has the likes of Infosys and Qualcomm sitting at its captable, with the founders holding a 33% equity ahead of IPO.
Source: inc42.com
Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
EBT-101 is a CRISPR-based therapeutic being developed as a potential functional cure for people living with HIVFirst-in-human trial is now open for enrollment SAN FRANCISCO, Jan. 27, 2022 (GLOBE NEWSWIRE)
Source: finanznachrichten.de
Investegate |Excision BioTherapeutics Announcements | Excision BioTherapeutics: Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Investegate announcements from Excision BioTherapeutics, Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Source: investegate.co.uk
Excision BioTherapeutics Appoints Infectious Disease Expert Sumathi Sivapalasingam, M.D, as Head of Translational Medicine
Excision BioTherapeutics Appoints Infectious Disease Expert Sumathi Sivapalasingam, M.D, as Head of Translational Medicine - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Excision BioTherapeutics Appoints Infectious Disease Expert
SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral...
Source: globenewswire.com
Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs Financing will support advancement of lead HIV potential cure program into clinical development
Published: Feb 17, 2021 SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc. (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the completion of a $60 million financing. The proceeds will be used to advance Excision’s lead candidate, EBT-101, into a Phase 1/2 clinical trial in patients with chronic HIV infection. The financing will also support preclinical programs including EBT-10...
Source: biospace.com